title: Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticholinergic Therapy In France.
authors.affiliation: Centre Hospitalier Lyon Sud, Pierre Bénite, France.
authors.forename: A
authors.initials: A
authors.lastname: Ruffion
authors.affiliation: Allergan France SAS, Courbevoie, France.
authors.forename: M
authors.initials: M
authors.lastname: Velard
authors.affiliation: Allergan Holdings Ltd., Marlow, UK.
authors.forename: C
authors.initials: C
authors.lastname: Loveman
authors.affiliation: Allergan, Inc, Irvine, CA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Khalaf
authors.affiliation: HEVA HEOR, Lyon, France.
authors.forename: S
authors.initials: S
authors.lastname: Roze
authors.affiliation: HEVA HEOR, Lyon, France.
authors.forename: M
authors.initials: M
authors.lastname: Pignata
authors.affiliation: The LASER Group, Milano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Stanisic
authors.affiliation: Laser Analytica, Loerrach, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Lister